Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2013-08-01 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RUMILLY (74150), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU SUD : revenue, balance sheet and financial ratios
PHARMACIE DU SUD is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RUMILLY (74150),
this company of category PME
shows in 2024 a net income positive of 410 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU SUD (SIREN 794387480)
Indicator
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
410 411 €
273 994 €
390 841 €
310 154 €
296 478 €
268 708 €
263 054 €
244 867 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DU SUD generates positive net income of 410 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 245 k€ -> 410 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
410 411 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
52.983%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.003%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Debt ratio
338.17
212.175
138.101
87.657
65.23
51.014
64.748
52.983
Financial autonomy
20.136
28.832
36.802
46.577
53.702
58.761
52.574
55.003
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
52.982024
2021
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good+12 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU SUD (52.98) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
55.0%2024
2021
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good-12 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU SUD (55.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 203.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
203.012
Liquidity indicators evolution PHARMACIE DU SUD
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
157.4
176.304
153.036
145.382
199.163
241.511
215.866
203.012
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
203.012024
2021
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good-12 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU SUD (203.01) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DU SUD in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU SUD is estimated at
5 729 640 €
(range 3 990 031€ - 8 571 870€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3990k€5729k€8571k€
5 729 640 €Range: 3 990 031€ - 8 571 870€
NAF 5 année 2024
Valuation method used
Net Income Multiple
410 411 €
×
14.0x
=5 729 641 €
Range: 3 990 031€ - 8 571 871€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU SUD with other companies in the same sector:
The revenue of PHARMACIE DU SUD is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU SUD profitable?
Yes, PHARMACIE DU SUD generated a net profit of 410 k€ in 2024.
Where is the headquarters of PHARMACIE DU SUD ?
The headquarters of PHARMACIE DU SUD is located in RUMILLY (74150), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE DU SUD ?
The tax return of PHARMACIE DU SUD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU SUD operate?
PHARMACIE DU SUD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart